市場調査レポート

商品コード

嚢胞性線維症肺疾患の世界市場：薬剤タイプ別、投与経路別、流通チャネル別、地域別、国別の分析、市場考察、予測

Global Cystic Fibrosis Lung Disease Market : Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast

出版日: 2024年01月01日 | 発行: Azoth Analytics

| ページ情報: 英文 250 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 2,450 384,062円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 2,950 462,442円

レポートPDFを同一企業内の全員にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の嚢胞性線維症肺疾患の市場規模は、2022年の107億5,000万米ドルから2029年末までに468億7,000万米ドルに達し、予測期間の2024年～2029年にCAGRで25.7%の成長が予測されています。

市場は治療介入の継続的な進歩によって後押しされています。製薬企業は革新的な治療法を前線に送り出すため、研究開発に多額の投資を行っています。さらに、遺伝子治療やCFTRモジュレーターのような新しい薬剤や治療法の登場は、嚢胞性線維症患者の治療情勢を著しく改善しています。これらの進歩は患者の予後を改善するだけでなく、市場全体の成長にも寄与しています。

さらに、医療従事者や患者の間で嚢胞性線維症に対する認識が高まっていることも、市場成長の重要な促進要因となっています。診断能力の向上と疾患教育への取り組みの強化は、早期発見と早期介入に寄与し、市場成長に寄与しています。

当レポートでは、世界の嚢胞性線維症肺疾患市場について調査し、市場規模と予測、地域とセグメントの分析、主な動向と機会などの情報を提供しています。

嚢胞性線維症肺疾患：ファクトシート
パイプラインにある肺の症状を標的とした嚢胞性線維症治療法
嚢胞性線維症の低分子療法とその標的変異
CF患者の遺伝子とドラッグデリバリーに一般的に使用される非ウイルスベクター
世界の嚢胞性線維症肺疾患市場：ダッシュボード
世界の嚢胞性線維症肺疾患市場：市場金額の評価（2019年～2029年）
世界の嚢胞性線維症肺疾患市場に対するCOVID-19の影響
世界の嚢胞性線維症肺疾患市場セグメンテーション：薬剤タイプ別
- 世界の嚢胞性線維症肺疾患市場、薬剤タイプ別、概要
- 世界の嚢胞性線維症肺疾患の市場規模：CFTRモジュレーター（金額）（2019年～2029年）
- 世界の嚢胞性線維症肺疾患の市場規模：気管支拡張薬（金額）（2019年～2029年）
- 世界の嚢胞性線維症肺疾患の市場規模：粘液溶解薬（金額）（2019年～2029年）
- 世界の嚢胞性線維症肺疾患の市場規模：抗感染症薬（金額）（2019年～2029年）
世界の嚢胞性線維症肺疾患市場セグメンテーション：投与経路別
- 世界の嚢胞性線維症肺疾患市場：投与経路別、概要
- 世界の嚢胞性線維症肺疾患の市場規模：経口（金額）（2019年～2029年）
- 世界の嚢胞性線維症肺疾患の市場規模：吸入（金額）（2019年～2029年）
- 世界の嚢胞性線維症肺疾患の市場規模：静脈（金額）（2019年～2029年）
世界の嚢胞性線維症肺疾患市場セグメンテーション：流通チャネル別
- 世界の嚢胞性線維症肺疾患市場：流通チャネル別、概要
- 世界の嚢胞性線維症肺疾患の市場規模：病院薬局（金額）（2019年～2029年）
- 世界の嚢胞性線維症肺疾患の市場規模：小売薬局（金額）（2019年～2029年）
- 世界の嚢胞性線維症肺疾患の市場規模：オンラインチャネル（金額）（2019年～2029年）

第4章世界の嚢胞性線維症肺疾患市場、地域分析

研究の地域範囲
地域のスナップショット

第5章南北アメリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

南北アメリカの嚢胞性線維症肺疾患市場：スナップショット
南北アメリカの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
南北アメリカの嚢胞性線維症肺疾患市場：主な要因
南北アメリカの嚢胞性線維症肺疾患市場：セグメント分析
南北アメリカの嚢胞性線維症肺疾患市場セグメンテーション：薬剤タイプ別
南北アメリカの嚢胞性線維症肺疾患市場セグメンテーション：投与経路別
南北アメリカの嚢胞性線維症肺疾患市場セグメンテーション：流通チャネル別
南北アメリカの嚢胞性線維症肺疾患市場セグメンテーション：国別
- 米国の嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- カナダの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- その他の南北アメリカの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）

第6章欧州の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

欧州の嚢胞性線維症肺疾患市場：スナップショット
欧州の嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
欧州の嚢胞性線維症肺疾患市場：主な要因
欧州の嚢胞性線維症肺疾患市場：セグメント分析
欧州の嚢胞性線維症肺疾患市場セグメンテーション：薬剤タイプ別
欧州の嚢胞性線維症肺疾患市場セグメンテーション：投与経路別
欧州の嚢胞性線維症肺疾患市場セグメンテーション：流通チャネル別
欧州の嚢胞性線維症肺疾患市場セグメンテーション：国別
- ドイツの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- 英国の嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- フランスの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- イタリアの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- スペインの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- その他の欧州の嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）

第7章アジア太平洋の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

アジア太平洋の嚢胞性線維症肺疾患市場：スナップショット
アジア太平洋の嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
アジア太平洋の嚢胞性線維症肺疾患市場：主な要因
アジア太平洋の嚢胞性線維症肺疾患市場：セグメント分析
アジア太平洋の嚢胞性線維症肺疾患市場セグメンテーション：薬剤タイプ別
アジア太平洋の嚢胞性線維症肺疾患市場セグメンテーション：投与経路別
アジア太平洋の嚢胞性線維症肺疾患市場セグメンテーション：流通チャネル別
アジア太平洋の嚢胞性線維症肺疾患市場セグメンテーション：国別
- 中国の嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- オーストラリアの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- インドの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
- その他のアジア太平洋の嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）

第8章中東・アフリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

中東・アフリカの嚢胞性線維症肺疾患市場：スナップショット
中東・アフリカの嚢胞性線維症肺疾患市場：市場規模とCAGR（2019年～2029年）
中東・アフリカの嚢胞性線維症肺疾患市場：主な要因
中東・アフリカの嚢胞性線維症肺疾患市場：セグメント分析
中東・アフリカの嚢胞性線維症肺疾患市場セグメンテーション：薬剤タイプ別
中東・アフリカの嚢胞性線維症肺疾患市場セグメンテーション：投与経路別
中東・アフリカの嚢胞性線維症肺疾患市場セグメンテーション：流通チャネル別

第9章市場力学

世界の嚢胞性線維症肺疾患市場に対する市場力学の影響の評価
促進要因
抑制要因
動向

第10章ポーターのファイブフォース分析

第11章競合ポジショニング

企業の製品ポジショニング
市場ポジションマトリクス
嚢胞性線維症肺疾患市場の市場シェア分析
企業プロファイル
- Vertex Pharmaceuticals
- Gsk plc
- Novartis AG
- Roche Holding AG
- Bayer AG
- Gilead Sciences
- Chiesi Farmaceutici S.p.A.
- Enterprise Therapeutics
- Laurent Pharma

図表

List of Figures

Figure 1: Global Cystic Fibrosis Lung Disease Market Size, By Value, 2019-2022 (USD Billion)
Figure 2: Global Cystic Fibrosis Lung Disease Market Size, By Value, 2023-2029 (USD Billion)
Figure 3: Global Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
Figure 4: Global Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 5: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By CFTR modulators, 2019-2029 (USD Billion)
Figure 6: Global Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 7: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Bronchodilators, 2019-2029 (USD Billion)
Figure 8: Global Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 9: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Mucolytics, 2019-2029 (USD Billion)
Figure 10: Global Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 11: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Anti infectives, 2019-2029 (USD Billion)
Figure 12: Global Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 13: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Oral, 2019-2029 (USD Billion)
Figure 14: Global Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 15: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Inhalation, 2019-2029 (USD Billion)
Figure 16: Global Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)`
Figure 17: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Intravenous, 2019-2029 (USD Billion)
Figure 18: Global Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 19: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Hospital Pharmacies, 2019-2029 (USD Billion)
Figure 20: Global Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 21: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Retail Pharmacies, 2019-2029 (USD Billion)
Figure 22: Global Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 23: Global Cystic Fibrosis Lung Disease Market Absolute Opportunity, By Online Channel, 2019-2029 (USD Billion)
Figure 24: Americas Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
Figure 25: Americas Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
Figure 26: Americas Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 27: Americas Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 28: Americas Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 29: Americas Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 30: Americas Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 31: Americas Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 32: Americas Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 33: Americas Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 34: Americas Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 35: Americas Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 36: United States Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 37: United States Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 38: United States Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 39: United States Cystic Fibrosis Lung Disease Market Share, By Route of Administration, By Value, 2022 (%)
Figure 40: United States Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 41: Canada Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 42: Canada Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 43: Canada Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 44: Canada Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 45: Canada Cystic Fibrosis Lung Disease Market Share, Distribution Channel, 2022 (%)
Figure 46: Rest of Americas Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 47: Rest of Americas Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 48: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 49: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 50: Rest of Americas Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 51: Europe Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
Figure 52: Europe Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
Figure 53: Europe Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 54: Europe Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 55: Europe Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 56: Europe Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 57: Europe Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 58: Europe Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 59: Europe Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 60: Europe Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 61: Europe Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 62: Europe Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 63: Germany Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 64: Germany Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 65: Germany Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 66: Germany Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 67: Germany Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 68: United Kingdom Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 69: United Kingdom Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 70: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 71: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 72: United Kingdom Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 73: France Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 74: France Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 75: France Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 76: France Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 77: France Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 78: Italy Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 79: Italy Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 80: Italy Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 81: Italy Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 82: Italy Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 83: Spain Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 84: Spain Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 85: Spain Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 86: Spain Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 87: Spain Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 88: Rest of Europe Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 89: Rest of Europe Cystic Fibrosis Lung Disease Market Value, By Drug Type, 2022 (USD Million)
Figure 90: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 91: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 92: Rest of Europe Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 93: Asia Pacific Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
Figure 94: Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
Figure 95: Asia Pacific Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 96: Asia Pacific Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 97: Asia Pacific Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 98: Asia Pacific Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 99: Asia Pacific Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 100: Asia Pacific Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 101: Asia Pacific Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 102: Asia Pacific Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 103: Asia Pacific Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 104: Asia Pacific Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 105: China Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 106: China Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
Figure 107: China Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 108: China Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 109: China Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 110: Australia Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 111: Australia Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
Figure 112: Australia Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 113: Australia Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 114: Australia Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 115: India Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 116: India Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
Figure 117: India Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 118: India Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 119: India Cystic Fibrosis Lung Disease Market Share, Distribution Channel, 2022 (%)
Figure 120: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market, By Value, 2019-2029 (USD Million & CAGR)
Figure 121: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Value, By Route of Administration, 2022 (USD Million)
Figure 122: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Drug Type, By Value, 2022 (%)
Figure 123: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Route of Administration, 2022 (%)
Figure 124: Rest of Asia Pacific Cystic Fibrosis Lung Disease Market Share, By Distribution Channel, 2022 (%)
Figure 125: Middle East and Africa Cystic Fibrosis Lung Disease Market Size, By Value, 2019H-2029F (USD Billion)
Figure 126: Middle East and Africa Cystic Fibrosis Lung Disease Market Share, By Drug Type, 2022 (%)
Figure 127: Middle East and Africa Cystic Fibrosis Lung Disease Market, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 128: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 129: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 130: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 131: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 132: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 133: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 134: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 135: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 136: Middle East and Africa Cystic Fibrosis Lung Disease Market, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
Figure 137: Market Share of Prominent Companies of Cystic Fibrosis Lung Disease Market, 2022 (%)
Figure 138: Vertex Pharmaceuticals Revenue, 2020-2022 (USD Billion)
Figure 139: Vertex Pharmaceuticals Revenue , By Products, 2022 (%)
Figure 140: Vertex Pharmaceuticals , By Geographic Segment, 2022 (%)
Figure 141: GSK PLC Revenue, 2020-2022 (USD Million)
Figure 142: GSK PLC Revenue , By Business Segments, 2022 (%)
Figure 143: GSK PLC Revenue, By Geography Segment, 2022 (%)
Figure 144: Novartis Revenue, 2020-2022 (USD Billion)
Figure 145: Novartis Revenue, By Business Segments, 2022 (%)
Figure 146: Novartis Revenue, By Geographical Segments, 2022 (%)
Figure 147: Roche Revenue, 2020-2022 (USD Billion)
Figure 148: Roche Revenue, By Business Segments, 2022 (%)
Figure 149: Roche Revenue, By Business Segments, 2022 (%)
Figure 150: Bayer AG Revenues, 2020-2022 (USD Million)
Figure 151: Bayer AG Revenues, By Geographic Segments, 2022 (%)
Figure 152: Bayer AG Revenues, By Business Segments, 2022 (%)
Figure 153: Gilead Sciences, Inc. Revenues, 2020-2022 (USD Million)
Figure 154: Gilead Sciences, Inc. Revenues, By Geographic Segments, 2022 (%)
Figure 155: Gilead Sciences, Inc. Revenue, By Therapeutic Area, 2022 (%)

List of Tables

Table A1: Cystic fibrosis Therapeutics in the pipeline

Table A2: Cystic fibrosis Small molecule therapies and their targeted mutations

Table A3: Non-viral vectors commonly used for gene and drug delivery in CF patients

Table A4: United States Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A5: United States Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A6: United States Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A7: United States Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A8: United States Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A9: United States Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A10: Canada Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A11: Canada Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A12: Canada Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A13: Canada Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A14: Canada Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A15: Canada Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A16: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A17: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A18: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A19: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A20: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A21: Rest of Americas Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A22: Germany Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A23: Germany Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A24: Germany Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A25: Germany Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A26: Germany Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A27: Germany Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A28: United Kingdom Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A29: United Kingdom Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A30: United Kingdom Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A31: United Kingdom Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A32: United Kingdom Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A33: United Kingdom Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A34: France Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A35: France Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A36: France Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A37: France Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A38: France Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A39: France Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A40: Italy Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A41: Italy Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A42: Italy Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A43: Italy Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A44: Italy Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A45: Italy Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A46: Spain Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A47: Spain Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A48: Spain Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A49: Spain Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A50: Spain Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A51: Spain Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A52: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A53: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A54: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A55: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A56: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A57: Rest of Europe Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A58: China Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A59: China Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A60: China Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A61: China Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A62: China Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A63: China Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A64: Australia Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A65: Australia Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A66: Australia Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A67: Australia Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A68: Australia Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A69: Australia Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A70: India Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A71: India Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A72: India Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A73: India Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A74: India Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A75: India Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A76: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2019-2022 (USD Million)

Table A77: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Drug Type, By Value, 2023-2029 (USD Million)

Table A78: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2019-2022 (USD Million)

Table A79: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Route of Administration, By Value, 2023-2029 (USD Million)

Table A80: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2019-2022 (USD Million)

Table A81: Rest of Asia Pacific Cystic Fibrosis Lung Diseases Market, By Distribution Channel, By Value, 2023-2029 (USD Million)

Table A82: Vertex Pharmaceuticals Key Company Financials, 2020-2022

Table A83: GSK PLC Key Company Financials, 2020-2022

Table A84: Novartis Key Company Financials, 2020-2022

Table A85: Roche Key Company Financials, 2020-2022

Table A86: Bayer AG Key Financials, 2020-2022

Table A87: Gilead Sciences, Inc. Key Financials, 2020-2022

Executive Summary

Azoth Analytics has released a research report titled "Cystic Fibrosis Lung Disease Market (2024 Edition)" which provides a complete analysis of the global Cystic Fibrosis Lung Disease industry in terms of market segmentation by Drug Type (CFTR Modulators, Bronchodilators, Mucolytics, Anti-infectives) and By Route of Administration (Oral, Inhalation, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Australia, India). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution. During the forecast period, 2024-2029, the Global Cystic Fibrosis Lung Disease market is expected to grow at a CAGR of 25.7%. The Global Cystic Fibrosis Lung Disease Market is expected to generate USD 46.87 Billion by the end of 2029, up from USD 10.75 Billion in 2022.

The cystic fibrosis lung disease market is propelled by continuous advancements in therapeutic interventions. Pharmaceutical companies are investing heavily in research and development to bring innovative treatments to the forefront. Moreover, the emergence of novel drugs and therapies, such as gene therapies and CFTR modulators, has significantly improved the treatment landscape for cystic fibrosis patients. These advancements not only enhance patient outcomes but also contribute to the overall growth of the market.

Additionally, the rising awareness of cystic fibrosis among healthcare professionals and patients is a significant driver for market growth. Improved diagnostic capabilities and increased disease education efforts contribute to early detection and intervention which is contributing to the market growth.

Scope of the Report

The report analyses the Cystic Fibrosis Lung Disease Market by Value (USD Billion).
The report presents the analysis of the Cystic Fibrosis Lung Disease Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The report analyses the Cystic Fibrosis Lung Disease Market by Drug Type (CFTR Modulators, Bronchodilators, Mucolytics).
The report analyses the Cystic Fibrosis Lung Disease Market By Route of Administration (Oral, Inhalation, Intravenous)
The report analyses the Cystic Fibrosis Lung Disease Market By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Channel).
The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, Drug Type, Route of Administration and Distribution Channels.
Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
The report also analyses the pipeline framework of the Dugs for the Cystic Fibrosis Lung Disease
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Vertex Pharmaceuticals, Gsk plc, Novartis AG, Roche Holding AG, Bayer AG, Gilead Sciences, Chiesi Farmaceutici S.p.A., Enterprise Therapeutics, and Laurent Pharma.

1. Market Background

1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Strategic Recommendations

3. Global Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

3.1 Cystic Fibrosis Lung Disease: Fact Sheet
3.2 Cystic fibrosis therapies targeting Lung symptoms in Pipeline
3.3 Cystic fibrosis small molecule therapies and their targeted mutations
3.4 Non-viral vectors commonly used for gene and drug delivery in CF patients
3.5 Global Cystic Fibrosis Lung Disease Market: Dashboard
3.6 Global Cystic Fibrosis Lung Disease Market: Market Value Assessment, 2019H-2029F (USD Billion)
3.7 Impact of COVID-19 on Global Cystic Fibrosis Lung Disease Market
3.8 Global Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
- 3.8.1 Global Cystic Fibrosis Lung Disease Market, By Drug Type Type Overview
- 3.8.2 Global Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- 3.8.3 Global Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- 3.8.4 Global Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- 3.8.5 Global Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
3.9 Global Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
- 3.9.1 Global Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
- 3.9.2 Global Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- 3.9.3 Global Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- 3.9.4 Global Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
3.10 Global Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
- 3.10.1 Global Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
- 3.10.2 Global Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies By Value, 2019H-2029F (USD Billion & CAGR)
- 3.10.3 Global Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 3.10.4 Global Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)

4. Global Cystic Fibrosis Lung Disease Market, Regional Analysis

4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

5.1 Americas Cystic Fibrosis Lung Disease Market: Snapshot
5.2 Americas Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
5.3 Americas Cystic Fibrosis Lung Disease Market: Key Factors
5.4 Americas Cystic Fibrosis Lung Disease Market : Segment Analysis
5.5 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
- 5.5.1 Americas Cystic Fibrosis Lung Disease Market, By Drug Type Overview
- 5.5.2 Americas Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- 5.5.3 Americas Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- 5.5.4 Americas Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- 5.5.5 Americas Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
- 5.6.1 Americas Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
- 5.6.2 Americas Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- 5.6.3 Americas Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- 5.6.4 Americas Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
5.7 Americas Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
- 5.7.1 Americas Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
- 5.7.2 Americas Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 5.7.3 Americas Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 5.7.4 Americas Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
5.8 Americas Cystic Fibrosis Lung Disease Market Segmentation : By Country
- 5.8.1 United States Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 5.8.1.1 United States Cystic Fibrosis Lung Disease Market, By Drug Type
  - 5.8.1.2 United States Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 5.8.1.3 United States Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 5.8.2 Canada Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 5.8.2.1 Canada Cystic Fibrosis Lung Disease Market, By Drug Type
  - 5.8.2.2 Canada Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 5.8.2.3 Canada Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 5.8.3 Rest of Americas Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 5.8.3.1 Rest of Americas Cystic Fibrosis Lung Disease Market, By Drug Type
  - 5.8.3.2 Rest of Americas Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 5.8.3.3 Rest of Americas Cystic Fibrosis Lung Disease Market, By Distribution Channel

6. Europe Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

6.1 Europe Cystic Fibrosis Lung Disease Market: Snapshot
6.2 Europe Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
6.3 Europe Cystic Fibrosis Lung Disease Market: Key Factors
6.4 Europe Cystic Fibrosis Lung Disease Market: Segment Analysis
6.5 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
- 6.5.1 Europe Cystic Fibrosis Lung Disease Market, By Drug Type Overview
- 6.5.2 Europe Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- 6.5.3 Europe Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- 6.5.4 Europe Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- 6.5.5 Europe Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
- 6.6.1 Europe Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
- 6.6.2 Europe Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- 6.6.3 Europe Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- 6.6.4 Europe Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
6.7 Europe Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
- 6.7.1 Europe Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
- 6.7.2 Europe Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 6.7.3 Europe Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 6.7.4 Europe Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
6.8 Europe Cystic Fibrosis Lung Disease Market Segmentation : By Country
- 6.8.1 Germany Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 6.8.1.1 Germany Cystic Fibrosis Lung Disease Market, By Drug Type
  - 6.8.1.2 Germany Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 6.8.1.3 Germany Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 6.8.2 United Kingdom Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 6.8.2.1 United Kingdom Cystic Fibrosis Lung Disease Market, By Drug Type
  - 6.8.2.2 United Kingdom Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 6.8.2.3 United Kingdom Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 6.8.3 France Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 6.8.3.1 France Cystic Fibrosis Lung Disease Market, By Drug Type
  - 6.8.3.2 France Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 6.8.3.3 France Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 6.8.4 Italy Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 6.8.4.1 Italy Cystic Fibrosis Lung Disease Market, By Drug Type
  - 6.8.4.2 Italy Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 6.8.4.3 Italy Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 6.8.5 Spain Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 6.8.5.1 Spain Cystic Fibrosis Lung Disease Market, By Drug Type
  - 6.8.5.2 Spain Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 6.8.5.3 Spain Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 6.8.6 Rest of Europe Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 6.8.6.1 Rest of Europe Cystic Fibrosis Lung Disease Market, By Drug Type
  - 6.8.6.2 Rest of Europe Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 6.8.6.3 Rest of Europe Cystic Fibrosis Lung Disease Market, By Distribution Channel

7. Asia-Pacific Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

7.1 Asia-Pacific Cystic Fibrosis Lung Disease Market: Snapshot
7.2 Asia-Pacific Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
7.3 Asia-Pacific Cystic Fibrosis Lung Disease Market: Key Factors
7.4 Asia-Pacific Cystic Fibrosis Lung Disease Market: Segment Analysis
7.5 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
- 7.5.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Drug Type Overview
- 7.5.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- 7.5.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- 7.5.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- 7.5.5 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Anti infectives, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
- 7.6.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
- 7.6.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- 7.6.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- 7.6.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
7.7 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation : By Distribution Channel
- 7.7.1 Asia-Pacific Cystic Fibrosis Lung Disease Market, By Distribution Channel Overview
- 7.7.2 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 7.7.3 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 7.7.4 Asia-Pacific Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)
7.8 Asia-Pacific Cystic Fibrosis Lung Disease Market Segmentation : By Country
- 7.8.1 China Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 7.8.1.1 China Cystic Fibrosis Lung Disease Market, By Drug Type
  - 7.8.1.2 China Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 7.8.1.3 China Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 7.8.2 Australia Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 7.8.1.1 Australia Cystic Fibrosis Lung Disease Market, By Drug Type
  - 7.8.1.2 Australia Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 7.8.1.3 Australia Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 7.8.3 India Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 7.8.3.1 India Cystic Fibrosis Lung Disease Market, By Drug Type
  - 7.8.3.2 India Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 7.8.3.3 India Cystic Fibrosis Lung Disease Market, By Distribution Channel
- 7.8.5 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Million & CAGR)
  - 7.8.5.1 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market, By Drug Type
  - 7.8.5.2 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market, By Route of Administration
  - 7.8.5.3 Rest of Asia-Pacific Cystic Fibrosis Lung Disease Market, By Distribution Channel

8. Middle-East & Africa Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

8.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Snapshot
8.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Market Size and CAGR, 2019H-2029F (USD Billion & CAGR)
8.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Key Factors
8.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market: Segment Analysis
8.5 Middle-East & Africa Cystic Fibrosis Lung Disease Market Segmentation: By Drug Type
- 8.5.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market, By Drug Type Overview
- 8.5.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By CFTR modulators, By Value, 2019H-2029F (USD Billion & CAGR)
- 8.5.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Bronchodilators, By Value, 2019H-2029F (USD Billion & CAGR)
- 8.5.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Mucolytics, By Value, 2019H-2029F (USD Billion & CAGR)
- 8.5.5 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Anti-infectives, By Value, 2019H-2029F (USD Billion & CAGR)
8.6 Middle-East & Africa Cystic Fibrosis Lung Disease Market Segmentation: By Route of Administration
- 8.6.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market, By Route of Administration Overview
- 8.6.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Oral, By Value, 2019H-2029F (USD Billion & CAGR)
- 8.6.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Inhalation, By Value, 2019H-2029F (USD Billion & CAGR)
- 8.6.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Intravenous, By Value, 2019H-2029F (USD Billion & CAGR)
8.6 Middle-East & Africa Cystic Fibrosis Lung Disease Market Segmentation: By Distribution Channel
- 8.6.1 Middle-East & Africa Cystic Fibrosis Lung Disease Market, By Distribution Channel: Overview
- 8.6.2 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Hospital Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 8.6.3 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Retail Pharmacies, By Value, 2019H-2029F (USD Billion & CAGR)
- 8.6.4 Middle-East & Africa Cystic Fibrosis Lung Disease Market Size, By Online Channel, By Value, 2019H-2029F (USD Billion & CAGR)

9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on Global Cystic Fibrosis Lung Disease Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Porter's Five Forces Analysis

11. Competitive Positioning

11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Cystic Fibrosis Lung Disease Market
11.4 Company Profiles
- 11.4.1 Vertex Pharmaceuticals
- 11.4.2 Gsk plc
- 11.4.3 Novartis AG
- 11.4.4 Roche Holding AG
- 11.4.5 Bayer AG
- 11.4.6 Gilead Sciences
- 11.4.7 Chiesi Farmaceutici S.p.A.
- 11.4.8 Enterprise Therapeutics
- 11.4.9 Laurent Pharma

嚢胞性線維症肺疾患の世界市場：薬剤タイプ別、投与経路別、流通チャネル別、地域別、国別の分析、市場考察、予測

Global Cystic Fibrosis Lung Disease Market : Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast

目次

第1章市場の背景

第2章戦略的推奨事項

第3章世界の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第4章世界の嚢胞性線維症肺疾患市場、地域分析

第5章南北アメリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第6章欧州の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第7章アジア太平洋の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第8章中東・アフリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第9章市場力学

第10章ポーターのファイブフォース分析

第11章競合ポジショニング

List of Figures

List of Figures

Executive Summary

Scope of the Report

Table of Contents

1. Market Background

2. Strategic Recommendations

3. Global Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

4. Global Cystic Fibrosis Lung Disease Market, Regional Analysis

5. Americas Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

6. Europe Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

7. Asia-Pacific Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

8. Middle-East & Africa Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

9. Market Dynamics

10. Porter's Five Forces Analysis

11. Competitive Positioning

嚢胞性線維症肺疾患の世界市場：薬剤タイプ別、投与経路別、流通チャネル別、地域別、国別の分析、市場考察、予測

Global Cystic Fibrosis Lung Disease Market : Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast

目次

第1章 市場の背景

第2章 戦略的推奨事項

第3章 世界の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第4章 世界の嚢胞性線維症肺疾患市場、地域分析

第5章 南北アメリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第6章 欧州の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第7章 アジア太平洋の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第8章 中東・アフリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第9章 市場力学

第10章 ポーターのファイブフォース分析

第11章 競合ポジショニング

List of Figures

List of Figures

Executive Summary

Scope of the Report

Table of Contents

1. Market Background

2. Strategic Recommendations

3. Global Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

4. Global Cystic Fibrosis Lung Disease Market, Regional Analysis

5. Americas Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

6. Europe Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

7. Asia-Pacific Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

8. Middle-East & Africa Cystic Fibrosis Lung Disease Market: Historic and Forecast (2019-2029)

9. Market Dynamics

10. Porter's Five Forces Analysis

11. Competitive Positioning

第1章市場の背景

第2章戦略的推奨事項

第3章世界の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第4章世界の嚢胞性線維症肺疾患市場、地域分析

第5章南北アメリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第6章欧州の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第7章アジア太平洋の嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第8章中東・アフリカの嚢胞性線維症肺疾患市場：実績と予測（2019年～2029年）

第9章市場力学

第10章ポーターのファイブフォース分析

第11章競合ポジショニング